Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704

FDA recall notice · announced February 5, 2020 · Mcguff Compounding Pharmacy Services

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704

Reason for recall

Presence of Particulate Matter: Particulates observed in vials release for dispensing.

Notes

Distribution: Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.
Lot/code information: Lot #18J1081, Exp 03/10/19
Quantity: N/A
Status: Terminated
Products in this recall event:
- Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704 (D-0821-2020)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.